HALO
Halozyme Therapeutics, Inc.
$80.84
$9.59B
Price
$80.84
Market Cap
$9.59B
Revenue CAGR (5Y)
+26.3%
EPS CAGR (5Y)
+53.5%
Revenue Growth
Year over Year+8.6%
2016
+115.8%
2017
-52.0%
2018
+29.1%
2019
+36.5%
2020
+65.7%
2021
+48.9%
2022
+25.6%
2023
+22.4%
2024
+37.6%
2025
EPS Growth
Year over Year-224.0%
2016
+156.8%
2017
-221.7%
2018
+10.7%
2019
+290.0%
2020
+201.1%
2021
-48.3%
2022
+43.9%
2023
+64.3%
2024
-24.6%
2025